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Acquired chromosomal instability and copy number
alterations are hallmarks of cancer. Enzymes
capable of promoting site-specific copy number
changes have yet to be identified. Here, we
demonstrate that H3K9/36me3 lysine demethylase
KDM4A/JMJD2A overexpression leads to localized
copy gain of 1q12, 1q21, and Xq13.1 without global
chromosome instability. KDM4A-amplified tumors
have increased copy gains for these same regions.
1q12h copy gain occurs within a single cell cycle,
requires S phase, and is not stable but is regenerated
each cell division. Sites with increased copy number
are rereplicated and have increased KDM4A, MCM,
and DNA polymerase occupancy. Suv39h1/KMT1A
or HP1g overexpression suppresses the copy gain,
whereas H3K9/K36 methylation interference pro-
motes gain. Our results demonstrate that overex-
pression of a chromatin modifier results in site-spe-
cific copy gains. This begins to establish how copy
number changes could originate during tumorigen-
esis and demonstrates that transient overexpression
of specific chromatin modulators could promote
these events.
INTRODUCTION
Genomic instability is a major contributing factor to the develop-
ment and onset of age-related diseases such as cancer (Maslov
and Vijg, 2009; Negrini et al., 2010). Cancer cells are often char-
acterized by copy number alterations: gains or losses of chromo-some arms and/or whole chromosomes as well as amplifications
of smaller genomic fragments (Beroukhim et al., 2010; Hook
et al., 2007; Stratton et al., 2009). Genome-wide analysis of
copy number changes in cancer has identified chromosomal re-
gions with higher frequencies of amplification, which often
contain putative oncogenes (Beroukhim et al., 2010). In some
cases, the oncogenes have been shown to impact cellular
behavior (e.g., MYC and MCL1), whereas other genes within
these regions do not have clear connections with tumorigenesis.
The lack of obvious connection does not preclude the gene’s
involvement. For example, cellular stresses can select for gene
amplification that will promote cancer cell survival, as exempli-
fied by the amplification of dihydrofolate reductase when cells
are treated with methotrexate (Schimke, 1984). Even though
cancer genomes frequently have altered chromosomal regions,
there is little knowledge about the regulatory mechanisms or fac-
tors that are involved in promoting copy number alterations at
specific regions of the genome.
Several mechanisms have been proposed for generating copy
number variation (CNV). For example, many models for DNA
amplification incorporate stalled replication forks and DNA
double-strand breaks that are generated during replication. It
has been proposed that these stalled/collapsed replication
forks are associated with and can cause tandem duplications.
A second mechanism proposed to contribute to CNV involves
the use of breaks or repair intermediates as primers for rereplica-
tion of specific stretches of DNA, which can reincorporate into
the genome, resulting in gene duplications or deletions. Alterna-
tively, it is also possible that these events will not integrate in the
genome (Hastings et al., 2009). A third mechanism that could
generate rereplicated fragments and copy number alteration is
the head-to-tail collision of elongating DNA polymerases (David-
son et al., 2006; Hook et al., 2007). Because chromatin structure
impacts replication initiation and elongation efficiency as well asCell 154, 541–555, August 1, 2013 ª2013 Elsevier Inc. 541
DNA damage response and repair (Alabert and Groth, 2012;
Papamichos-Chronakis and Peterson, 2013), the chromatin
state or modifying enzyme(s) could have a significant impact
on each of these possible mechanisms.
Recently, Kiang and colleagues demonstrated that local DNA
fragment amplification occurs during S phase (Kiang et al., 2010)
and that the chromatin context or chromosome microenviron-
ments play amajor role in this process. Consistent with an impor-
tant role for the chromatin context, misregulation of the histone 4
lysine 20 monomethyltransferase KMT5A (H4K20me1, PR-Set7/
Set8) promotes rereplication, at least in part, by increasing
H4K20me2/3 levels and promoting ORC recruitment through
binding of H4K20me2 (Beck et al., 2012; Kuo et al., 2012; Tardat
et al., 2010). However, the role ofmethylation inmodulating repli-
cation is not limited to the direct recruitment of DNA replication
factors. For example, we have previously demonstrated that
the H3K9me3 demethylase KDM4A/JMJD2A was able to in-
crease accessibility and alter the replication timing at specific
heterochromatic regions (Black et al., 2010). The regulation of
KDM4A protein levels is also important in modulating its chro-
matin occupancy, replication initiation, and S-phase progression
(Van Rechem et al., 2011). Furthermore, Mallette and colleagues
demonstrate that increased KDM4A expression abrogates
53BP1 recruitment to DNA damage sites, suggesting a role for
KDM4A in DNA damage response (Mallette et al., 2012). There-
fore, we hypothesize that overexpression of catalytically active
KDM4A may provide a potential enzymatic link to the proposed
methods for generating copy number alterations through replica-
tion abnormalities, which may contribute to copy number
changes in cancer.
In this study, we analyzed The Cancer Genome Atlas (TCGA)
data and observed that KDM4A is amplified and overexpressed
in several tumor types. KDM4A overexpression in transgenic
cells was sufficient to promote copy gain of specific chromo-
somal domains (e.g., 1q12). KDM4A-dependent copy gain
was induced in less than 24 hr and required S phase. These
copy gains were not stably inherited but were generated tran-
siently in each subsequent S phase and cleared by late G2.
KDM4A was the only KDM4 family member that generated the
gains in a catalytically dependent manner. These copy gains
were antagonized by coexpression of Suv39h1/KMT1A or
HP1g, and H3K9 or H3K36 methylation interference promoted
gain. Furthermore, KDM4A associated with replication machin-
ery and promoted rereplication of regions exhibiting copy gain.
KDM4A overexpression increased KDM4A, MCM, and DNA po-
lymerase association as well as decreased HP1g occupancy at
regions that undergo KDM4A-dependent rereplication. Interest-
ingly, focal amplifications of 1q21 and Xq13.1 were correlated
with KDM4A amplification in tumors, which was recapitulated
in KDM4A-overexpressing cell lines. Our findings demonstrate
that KDM4A overexpression results in site-specific copy gain
of regions amplified in human tumors.
RESULTS
KDM4A Is Amplified and Overexpressed in Cancer
KDM4A has previously been demonstrated to be overexpressed
in breast and lung cancer (Berry et al., 2012; Mallette and542 Cell 154, 541–555, August 1, 2013 ª2013 Elsevier Inc.Richard, 2012). However, a comprehensive profile of primary
tumors for alterations in KDM4A expression levels has yet to be
established. There are few insights into the mechanisms that
promote increased expression in tumors. Therefore,weconduct-
ed a comprehensive analysis of KDM4A copy number and ex-
pression level in 1,770primary tumor samples fromeight different
cancer types (Figure S1 available online) represented in TCGA
(Beroukhim et al., 2010). We found evidence of increased
KDM4A copy number (GISTIC annotation of +1 or +2; Mermel
et al., 2011) in 18.9% of tumors (335 out of 1,770 samples;
Figure 1A) and copy loss in 22.1% of tumors (392 out of 1,770
samples; Figure 1A). Furthermore, amplification or deletion of
KDM4A resulted in increased or decreased KDM4A expression,
respectively (Figures 1B and Figure S1A). KDM4A was both
amplified and deleted across many disparate cancer types, and
KDM4A expression correlated with copy number in these sam-
ples (Figures S1E–S1L). We also observed amplification and
deletion ofKDM4B-D in cancer,which correlatedwith expression
(Figures S1B–S1D). These data provide a molecular basis for the
elevated KDM4A levels observed in different tumor samples.
Ovarian cancer was significantly enriched for KDM4A amplifi-
cation, which was amplified in 46% of the tumors (94 out of 204,
p = 1.4 3 1021 for gain versus no change and loss by Fisher’s
exact test), with relatively few examples of deletion (9.8%; 20
out of 204, samples) (Figures 1C and S1I). The amplification of
KDM4A in ovarian cancer also correlated with increased expres-
sion (Figures 1D and S1I). In addition, KDM4A focal amplification
(GISTIC +2) was significantly associated with the time to death in
the ovarian cancer patient data set, with a median time to death
of 691 days compared to 1,052 days without KDM4A amplifica-
tion (Figure 1E, p = 0.02); however, KDM4A loss (GISTIC 2 or
1) was not significantly different from patients without changes
in KDM4A copy number (p = 0.85). In sharp contrast to KDM4A,
few cases of focal amplifications were observed for KDM4B-D,
and no statistical significance was associated with their focal
amplifications and time to death (Figures 1F–1H). However, focal
deletion of KDM4C (GISTIC 2) and broad loss or gain (GISTIC
1 or +1) of KDM4D modestly associated with poor outcome
(p = 0.014, p = 0.013, and p = 0.018, respectively). These data
highlight the differences between the KDM4 family and cancer
outcome, which suggests nonoverlapping functions in certain
cancer types. These data also suggest that KDM4A levels could
function as a biomarker in ovarian cancer.
KDM4A Overexpression Promotes Copy Gain of 1q12
We previously demonstrated that KDM4A overexpression
promoted faster S-phase progression, increased chromatin
accessibility, and altered replication timing (Black et al., 2010).
KDM4A was also shown to impact the DNA damage response
(Mallette et al., 2012). For these reasons, we hypothesized that
KDM4A overexpression may promote genomic instability, which
is a hallmark of cancer (Luo et al., 2009; Hanahan andWeinberg,
2011). Therefore, we stably overexpressed KDM4A in the
karyotypically stable and immortalized, but not transformed,
RPE1-hTERT (RPE) cell line (GFP, referred to as control or
CTRL; GFP-KDM4A, referred to as KDM4A) (Jiang et al., 1999).
Similar to our previously reported 293T stable cells (Figure S2A),
RPE stable cell lines expressed KDM4A about 2- to 3-fold over
Figure 1. KDM4A Is Amplified and Overexpressed in Cancer and
Correlates with Poor Outcome in Ovarian Cancer
(A) Distribution of gain (GISTIC annotation +1 or +2) or loss (GISTIC annotation
1 or 2) of copy of KDM4A in 1,770 cancer samples.
(B) Amplification of KDM4A correlates with increased expression of KDM4A in
TCGA.
(C) KDM4A is frequently amplified in ovarian cancer (p = 1.4 3 1021 for gain
versus no change and loss by Fisher’s exact test).
(D) Amplification of KDM4A in ovarian cancer correlates with increased
expression of KDM4A.
(E) Focal amplification of KDM4A in ovarian cancer correlates with
poor outcome in 285 deceased ovarian cancer samples (p = 0.02 by one-
tailed Student’s t test and 0.048 by one-tailed, Wilcoxon rank sum test for +2
versus 0).
(F) Copy number ofKDM4B does not correlate with outcome in ovarian cancer.
(G) Deletion ofKDM4C in ovarian cancer correlates with outcome (p = 0.014 for
loss versus none).
(H) Copy number loss and gain of KDM4D correlate with outcome in ovarian
cancer (p = 0.018 for gain versus none and 0.013 for loss versus none by
Student’s t test).
Asterisk indicates significant difference from no change samples (p < 0.05).
RPKM denotes reads per kilobase exon model per million reads of RNA-seq
data (see the Extended Experimental Procedures). See also Figure S1.endogenous level (Figure S2B). Upon spectral karyotyping these
cell lines, we did not observe major genomic events that were
specific to the KDM4A cell lines when compared to CTRL cell
lines (SKY; Figures 2A and 2B and Table S1). Similarly, G-bandanalysis of a 293T KDM4A-overexpressing stable cell line did
not document any amplification, deletion, or translocation spe-
cific to GFP-KDM4A cells (data not shown). These data support
the notion that modest KDM4A overexpression does not pro-
mote large-scale genomic instability.
We reasoned that KDM4Amight promote instability at specific
genomic loci that could be below the detection threshold of SKY.
In order to identify these candidate regions, we reanalyzed our
chromatin immunoprecipitation (ChIP) on chip analysis of
KDM4A binding in 293T cells (Figure S2C) (Van Rechem et al.,
2011) for KDM4A enrichment by cytogenetic band. Of the top
ten enriched cytogenetic bands, only 1q12 was specifically en-
riched in KDM4A-overexpressing cells when compared to con-
trol cells (Figure S2C). 1q12/21 is a region with frequent CNV in
lung cancer, multiple myeloma, and congenital heart abnormal-
ities and has been described as a susceptibility locus for schizo-
phrenia and autism (Brunet et al., 2009; Brzustowicz et al., 2000;
Inoue et al., 2004; Yakut et al., 2006). To determine whether the
copy number of 1q12 was altered following manipulation of
KDM4A protein levels, we performed fluorescent in situ hybridi-
zation (FISH) in CTRL and KDM4A-overexpressing 293T cells
(Figures 2C–2K and S2D). KDM4A overexpression resulted in
increased copy number of 1q12h in 14% of cells (Figure 2K),
which was not due to a gain of the entire 1q chromosome arm,
as the 1q telomere did not have an increase in copy number (Fig-
ure 2K; 1qTel). Furthermore, no other gains occurred at addi-
tional pericentric regions (Figure 2K). We further validated these
results in the RPE stable cell lines used in the SKY analysis (Fig-
ures 2A, 2B, S2B). Similar to the 293T cells, 17% of KDM4A-
overexpressing RPE cells showed an increase in copy of
1q12h, whereas no significant changes in copy number were
observed for the 1q telomere or other centromeres on chromo-
somes 2, 6, 8, or X (Figures 2L–2T; Chr 2, 6, 8, X).
To eliminate the possibility that KDM4A promoted chromatin
accessibility so that there was increased 1q12h detection, con-
densin 1 (CapD2) or condensin 2 (CapD3) were depleted from
cells (Figure S2F). Depletion of either condensin did not increase
detection of 1q12h amplification in CTRL or KDM4A cells (Fig-
ure S2G). Therefore, the increased copy number of 1q12h in
KDM4A cells is most likely not an artifact of increased chromatin
accessibility. Furthermore, 1q12h copy gain was not due to alter-
ations in p53 activity, as doxorubicin treatment resulted in p53
stabilization and target gene activation in CTRL and KDM4A cells
(Figures S2H and S2I).
KDM4A-Dependent 1q12h Copy Gain Is Dose
Dependent and Requires Catalytic Activity and Tudor
Domains
In order to determine whether the expression level and catalytic
activity of KDM4A are required for 1q12h copy gain, we overex-
pressed catalytically active and inactive KDM4A (H188A; Whets-
tine et al., 2006) with and without KDM4A depletion by shRNA
(Figures 3A and S3A). Transient overexpression of KDM4A was
sufficient to promote 1q12h copy gain but not alter copy number
of Chr 8. However, concomitant depletion of KDM4A sup-
pressed 1q12h gain, which demonstrates the importance of
increasing KDM4A levels in order to observe 1q12h gain (Figures
3A and S3A). Importantly, neither catalytically dead KDM4ACell 154, 541–555, August 1, 2013 ª2013 Elsevier Inc. 543
Figure 2. KDM4A Overexpression Results in 1q12h Copy Gain
(A and B) SKY analysis of RPE GFP-CTRL and GFP-KDM4A cells.
(C–J) FISH of stable 293T cells overexpressing GFP-CTRL or GFP-KDM4A, respectively. DAPI, (C) and (G); 1q12h (green), (D) and (H); Chr 8 centromere (red), (E)
and (I); merged images in (F) and (J).
(K) Quantification of FISH experiments in stable 293T GFP-CTRL (black bars) and GFP-KDM4A cells (red bars) with the indicated FISH probes.
(L–S) FISH of stable RPE cells overexpressing GFP-CTRL or GFP-KDM4A, respectively. DAPI, (L) and (P); 1q12h (green), (M) and (Q); Chr 8 (red), (N) and (R);
merged images in (O) and (S).
(T) Quantitation of RPE FISH experiments.
Arrowheads indicate foci in FISH images. Error bars represent the SEM. Asterisk indicates significant difference from GFP-CTRL (p < 0.05) by two-tailed Stu-
dent’s t test. Scale bars, 2 mm. See also Figure S2 and Table S1.overexpression (Figures 3A and 3B; H188A) nor KDM4A deple-
tion promoted 1q12h copy gain, which emphasizes that the
gain is not a dominant-negative effect due to KDM4A
overexpression.
We further demonstrated that 1q12h gain occurred in less than
24 hr of KDM4A transient overexpression in RPE cells (Figures
3C, 3D, S3B, and S3C) while not altering copy gain at other re-
gions (Figure 3D). Interestingly, KDM4B, KDM4C, or KDM4D544 Cell 154, 541–555, August 1, 2013 ª2013 Elsevier Inc.overexpression for 24 hr did not alter 1q12h copy number (Fig-
ures 3E and S3C). The copy gain required KDM4A catalytic ac-
tivity (H188A) and enzymatic domains (JmjC and JmjN; referred
to as DNC) in RPE cells (Figures 3B, 3C, and S3B). However, the
KDM4A catalytic domain alone was insufficient to generate
1q12h gain (Figures 3B and 3C; referred to as NC). Interestingly,
the loss of the Tudor domains alone was sufficient to block the
1q12h gain (Figures 3B and 3C; referred to as NCMP). Taken
Figure 3. 1q12h Copy Gain Can Be Induced
Transiently, Depends on KDM4A Catalytic
Activity, and Can Be Antagonized by
Suv39h1 and HP1g
(A) Quantification of FISH experiments in 293T
cells overexpressing CTRL, KDM4A, or catalyti-
cally inactive KDM4A (H188A) with (+) and without
(–) depletion of endogenous KDM4A (sh4A.1) with
the indicated FISH probes.
(B) Schematic of NHF-tagged KDM4A constructs.
The subcellular localization (‘‘location’’) occurred
in >80% of assayed cells, and catalytic activity
(‘‘+’’) indicates strong reduction in total nuclear
H3K36me3.
(C and D) Quantification of FISH experiments with
indicated probes in RPE cells transfected for 24 hr
with the indicated constructs. (C) NHF-KDM4A
constructs. (D) GFP-CTRL (black bars) or GFP-
KDM4A (red bars).
(E) 1q12h copy gain is specific to KDM4A over-
expression and not other KDM4 family members.
(F) Overexpression of H3.3 histone variants for
H3K9 or H3K36 promotes 1q12h gain.
(G and H) Coexpression of Suv39h1 (G) or HP1g
(H) abrogates KDM4A-dependent 1q12h gain.
Error bars represent the SEM. Asterisk indicates
significant difference from GFP-CTRL or NHF-
CTRL, or H3.3 WT, or comparison indicated by
brackets (p < 0.05) by two-tailed Student’s t test.
See also Figure S3.together, these data emphasize that transient exposure to
increased KDM4A levels is sufficient to promote 1q12h copy
gain, but this can only occur with a catalytically active enzyme
and functional Tudor domains.
Interfering with H3K9 or H3K36 Methylation Promotes
1q12 Copy Gain
The requirement for KDM4A catalytic activity to promote 1q12
copy gain suggests that demethylation of chromatin or a nonhis-
tone target is important for proper regulation of 1q12h ploidy.
Recently, Lewis and colleagues demonstrated that H3.3 variants
with a methionine in place of the lysine (i.e., H3K27M, H3K9M,
and H3K36M) can inhibit EZH2 (K27M), G9a (K9M), and
Suv39h1 (K9M), as well as reduce H3K36me3 levels (K36M)
(Lewis et al., 2013). Therefore, these H3.3 variants were used
to ascertain whether interfering with methylation at any one of
these lysines could promote 1q12h copy gain. Each variant
was expressed and successfully incorporated into chromatin in
24 hr and reduced the corresponding trimethylation (Figures
S3D andS3E). Expression of H3.3WT,G34V, andH3K27M failed
to promote 1q12h copy gain; however, expression of either
H3.3K9M or H3.3K36M was sufficient to promote 1q12h gain
(Figure 3F; p = 0.026 for K9M and p = 0.006 for K36M). Further-Cell 154, 541–55more, the 1q12h gain was not caused by
a gain of chromosome 1, as there was not
an increase in 1q Tel or in the 1q23.3 cy-
togenetic band midway down the 1q arm
(Figure 3F). Because H3.3K9M promoted
copy gain at 1q12h and inhibits Suv39h1(Lewis et al., 2013), we reasoned that overexpression of the
H3K9me3 methyltransferase Suv39h1 may suppress KDM4A-
dependent copy gain. Consistent with this prediction, coexpres-
sion of Halo-Suv39h1 was sufficient to abrogate KDM4A-depen-
dent 1q12h copy gain (p = 0.0003 for KDM4A vs NHF; p = 0.0055
for KDM4A + Suv39h1 vs KDM4A; and p = 0.47 for KDM4A+
Suv39h1 vs NHF) (Figures 3G and S3F). These results highlight
the importance of methylation in modulating site-specific copy
gain, especially the lysines that are substrates for KDM4A.
HP1g Antagonizes KDM4A-Dependent Increased 1q12
Copy Number
KDM4A-dependent changes in cell-cycle progression and
replication timing at Chr1 sat2 are antagonized by HP1g over-
expression (Black et al., 2010). Therefore, we hypothesized that
HP1g overexpression could antagonize the increased copy
number of 1q12 in KDM4A-overexpressing cells. Cotransfection
of HP1g reduced the 1q12h copy gain to levels comparable
to that seen in control cells (p = 0.29 for KDM4A + HP1g vs
GFP-CTRL+ HP1g; and p = 0.009 for KDM4A + HP1g vs
KDM4A + RFP-CTRL) (Figures 3H and S3G). Surprisingly, trans-
fection of HP1g into RPE cells stably overexpressing KDM4A
or stably co-overexpressing HP1g and KDM4A did not reverse5, August 1, 2013 ª2013 Elsevier Inc. 545
Figure 4. 1q12h Copy Gain Is Not Stably
Inherited and Requires S Phase Each Cell
Cycle
(A) Increased 1q12h copy number in GFP-KDM4A
RPE cells is not inherited. FISH of single-cell
clones derived from RPE KDM4A cells.
(B) Average copy gain for 27 single-cell clones
from (A) is graphically depicted.
(C) Increased copy number of 1q12h requires
S phase.
(D) 1q12h gain is lost by the end of G2.
(E and F) 1q12h copy gain is generated in S phase.
Stable GFP-CTRL (E) and GFP-KDM4A (F) RPE
cells were arrested in hydroxyurea (HU) for 20 hr
and released for the time indicated prior to FISH
analysis.
Error bars represent the SEM. Asterisk indicates
significant difference from GFP-CTRL or com-
parison indicated by bracket (p < 0.05) by two-
tailed Student’s t test. For the HU release, p values
are based on the comparison of KDM4A to CTRL
at each individual time point (F and E, respec-
tively). See also Figure S4.the increased copy number of 1q12h (data not shown). These
results imply that, once an altered chromatin conformation is
established, HP1g is insufficient to restore proper regulation of
1q12 copy number in KDM4A overexpressing cells.
1q12 Copy Gain Is Not Stably Inherited and Requires
S Phase
Because KDM4A overexpression promotes 1q12 gain, we asked
whether the increased copy number was stably inherited or was
regenerated during subsequent cell cycles. First, single-cell
clones were established from our stably overexpressing
KDM4A RPE cell line and were assayed by 1q12h FISH (Fig-
ure 4A). If the copy number of 1q12h was stably inherited,
some clones should have 100% of cells with 1q12h copy gain.
Instead, we observed a distribution of copy gain between 1.5%
and 37%, which supports the model that 1q12 gain is most likely
not stably inherited (Figures 4A and S4A). The clones lacking
increased copy of 1q12h (below black dashed line) no longer
overexpressed KDM4A (Figure S4A). Furthermore, the average
of all clones assayed was 17.0%, agreeing with our analysis of
the starting stable population (Figures 4B and 2T, respectively).
We next investigated whether stably overexpressing KDM4A
RPE cells gain extra copies of 1q12h during each cell division.
The 1q12h copy gain was eliminated in KDM4A overexpressing
RPE cells arrested in G1/S with HU (Figures 4C and S4B).
Because apoptosis was not increased in asynchronous or HU-
arrested KDM4A cells, the lack of copy gain was not due to546 Cell 154, 541–555, August 1, 2013 ª2013 Elsevier Inc.r
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fincreased apoptosis removing cells with
extra 1q12h (Figure S4C). However,
doxorubicin treatment could induce
apoptosis in both CTRL and KDM4A
cells, which was significantly reduced
in KDM4A-overexpressing cells (Figure
S4C). We then tested whether 1q12h
gain persisted through G2 by arresting
cells in late G2 with the CDK1 inhibitoR03306 (Figure S4B; Vassilev, 2006). KDM4A cells arrested in
late G2 and did not display 1q12h copy gain (Figure 4D).
Given that KDM4A-dependent 1q12h copy gain did no
occur during G1/S or G2 arrest, we hypothesized that KDM4A
promotes copy gain during S phase. In agreement with this
hypothesis, GFP-KDM4A cells, but not GFP-CTRL cells, were
able to promote additional copies of 1q12h, but not Chr 8 cen-
tromere following HU release (Figures 4E and 4F). The additiona
copies occurred between 2 and 6 hr post-HU release and were
lost between 8 and 10 hr following release. Taken together, our
data support a model whereby KDM4A promotes copy gain o
specific chromosomal regions during S phase, which are then
eliminated by the end of the G2 phase of cell cycle.
KDM4A Associates with Replication Machinery and
Promotes Rereplication of 1q12
In order to gain molecular insight into how KDM4A is involved in
generating 1q12h copy gain, we identified KDM4A-interacting
proteins by performing mass spectrometry analysis of proteins
interacting with Halo-KDM4A. We observed a significant enrich-
ment for proteins involved in replication using IPA (Figure 5A; p =
0.00000795). Interestingly, many of these proteins are required
for rereplication (e.g., MCMs and DNA polymerases; Arias and
Walter, 2007; Snaith and Forsburg, 1999).
Previous work verified KDM4A associations with cullin 1 (Van
Rechem et al., 2011) and p53 (Kim et al., 2012). We further vali-
dated additional interactions by conducting endogenous
Figure 5. KDM4A Interacts with Replication Machinery, and KDM4A Overexpression Promotes Rereplication
(A) Table depicting mass spectrometry analysis of KDM4A-interacting proteins related to replication.
(B) Western blots of coimmunoprecipitation of endogenous KDM4A and the indicated licensing and replication machinery in RPE Cells.
(C) KDM4A overexpression in RPE cells leads to rereplication of Chr1 sat2.
(D) KDM4A is enriched at Chr1 sat2 (1q12) in HU-arrested KDM4A-overexpressing RPE cells.
(E) H3K9me3, but not H3K36me3, decreases at Chr1 sat2 in HU-arrested cells.
(F) HP1g enrichment decreases at Chr1 sat2 (1q12) in HU-arrested KDM4A-overexpressing cells.
(G and H) MCM7 and DNA polymerase a (Pol a) are enriched at Chr1 sat2 (1q12) in HU-arrested KDM4A-overexpressing cells.
Error bars represent the SEM. Asterisk indicates significant difference from GFP-CTRL or comparison indicated by bracket (p < 0.05) by two-tailed Student’s
t test. See also Figure S5.KDM4A coimmunoprecipitation with MCM2, MCM3, and MCM7
or Halo-tagged DNA polymerase subunits (Figures 5B and S5A).
Although MCM2 was not identified in our mass spectrometry
analysis, it associated with KDM4A, suggesting that the entire
MCM complex interacts with KDM4A.
Because KDM4A overexpression promoted copy gain in a
replication-dependent manner and interacted with DNA poly-
merases and the replication licensing machinery, we hypothe-
sized that KDM4A overexpression was promoting rereplication
within 1q12. To test this hypothesis, we utilized cesium chloride
density gradient centrifugation (Figure S5B). Our labeling proce-
dure was performed for less than one complete cell cycle, pro-
ducing an enrichment in heavy-light (H:L)-replicated DNA whilestill maintaining an unreplicated light-light fraction (L:L). We did
not detect a peak of enrichment of H:H DNA, indicating that
KDM4A overexpression does not promote widespread rerepli-
cation, as seen with other chromatin regulators (KMT5A; Tardat
et al., 2010). We pooled and purified the fractions in which the
H:H DNA should separate and then assayed the rereplicated
DNA for specific regions. Because Chr1 sat2 resides in 1q12
(Wong et al., 2001) and is bound and modulated by KDM4A,
we reasoned that it could be a rereplicated target. We observed
a 7-fold enrichment of Chr1 sat2 in the rereplicated fraction from
KDM4A-overexpressing cells, whereas the b-actin locus and a
region near the X centromere, which we previously reported as
a KDM4A target (Black et al., 2010), were not enriched (FiguresCell 154, 541–555, August 1, 2013 ª2013 Elsevier Inc. 547
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5C and S5C). The enrichment in Chr1 sat2 rereplication repre-
sented a small amount of the input DNA and was consistent
with a subpopulation of cells generating and losing the 1q12h
copy gain (Figure S5C). Taken together, our data demonstrate
that KDM4A associates with replication proteins and promotes
rereplication at a specific locus that exhibits copy gains.
KDM4A Overexpression Promotes Chromatin State
Changes and Recruitment of Replication Machinery
Our data support a model whereby KDM4A overexpression
promotes methylation changes, displacement of HP1g, and
recruitment of replication machinery to specific genomic re-
gions, resulting in rereplication. To test this model, we performed
ChIP experiments to evaluate methylation levels, HP1g enrich-
ment, and replication machinery occupancy at Chr1 sat2. As a
negative control, we identified an intergenic region on chromo-
some 10 (Chr10) that is acetylated at H3K9 in numerous cell
types (according to UCSC browser; data not shown) that should
not be enriched for H3K9me3 or KDM4A. KDM4A overexpres-
sion increased KDM4A recruitment to Chr1 sat2, but not Chr10
(Figure 5D), which corresponded to a loss of H3K9me3 and
HP1g depletion (Figures 5E and 5F). We did not observe any
change in H3K36me3 at Chr1 sat2, which was consistent with
our previous findings in 293T cells (Black et al., 2010). Finally,
both MCM7 and Pola were enriched at Chr1 sat2, but not at
Chr10, upon KDM4A overexpression (Figures 5G and 5H,
respectively). Our data demonstrate that KDM4A overexpres-
sion promotes H3K9me3 and HP1g loss, increased replication
machinery recruitment, and rereplication.
Identification of Regions Coamplified with KDM4A in
Cancer
To identify additional regions that have copy gains upon KDM4A
overexpression, we determinedwhetherKDM4A focal amplifica-
tion (1p34.2) in primary tumors was correlated with copy gains of
any of the 807 cytogenetic bands in 4,420 tumor samples (Fig-
ure 6A, which represents 19 tumor types, including the 8
analyzed in Figure S1). We observed correlated copy gains
from 1p11.2 through 1q21.3 on chromosome 1 in two indepen-
dent statistical tests (Figures 6A and S6A, blue shading; see
Experimental Procedures). Due to theminimal sequence annota-
tion and repetitive nature of 1q12, we did not calculate a corre-
lation for this cytogenetic band. However, the cytogenetic bandsFigure 6. Identification of Cytogenetic Bands Coamplified with KDM4A
(A) Focal amplification of cytogenetic bands correlates with amplification of KDM4
significance is p = 1.5 3 1037.
(B) Focal amplification of cytogenetic bands with amplification of KDM4B. The b
(C) Focal amplification of cytogenetic bands correlates with amplification of KDM4
and its gene-specific significance is p = 1.1 3 1019. For each coamplification pl
indicate Xp11.2 through Xq13.2.
(D) Increased copy ofKDM4A is associated with increasedmean focal copy of 1q2
exact test.
(E) Increased copy of KDM4A is associated with increased copy of 1q21.2 (p = 1
(F) Increased copy of KDM4A is associated with increased copy of 1q21.3 (p = 1
(G) Increased copy number of KDM4B is not associated with increased copy of
(H) Increased copy number of KDM4B is not associated with increased copy of
(I) Increased copy number of KDM4B is not associated with increased copy num
Asterisk indicates significant difference of +1 or +2 versus 0 by Fisher’s exact teimmediately flanking 1q12 (1p11.2 and 1q21.1) exhibited co-
gain with KDM4A amplification, which suggests that 1q12 is
likely coamplified in these tumors. These coamplified regions
were specific to KDM4A because there was not a strong cor-
relation when the identical analysis was performed with respect
to KDM4B coamplification (Figures 6B and S6B). We ob-
served that individual coamplified regions could universally be
observed, whereas others could be differentially regulated in
a tumor- and/or tissue-specific manner. For example, the
ovarian cancer data sets demonstrated coamplification with
1p11.2-1q21.3, whereas some KDM4A-coamplified regions
were lost (e.g., the region on 17q positions 17q24.2 to
17q25.3) and others were enhanced (e.g., the region on X chro-
mosome positions Xp11.2 to Xq13.2) in the ovarian cancer pro-
file (Figures 6C and S6C).
Next, we tested whether gains in 1q21.1-1q21.3 were affected
by the amplification level of KDM4A (Figures 6D–6F and S6D–
S6F). Indeed, when KDM4A had a high-level focal amplification
(GISTIC +2), a significantly greater fraction of samples were
amplified in 1q21.1-1q21.3 compared to cases in which KDM4A
was not amplified (GISTIC 0; Fisher’s exact test; p = 2 3 109
in 1q21.1, 1.9 3 109 in 1q21.2, and 1.02 3 1010 in 1q21.3)
(Figures 6D–6F). When comparing lower-level amplification of
KDM4A (GISTIC +1) to the KDM4A-unamplified cases, we
observed a reduced sample fraction but still highly significant
amplification of 1q21.1-1q21.3 (p = 2.04 3 1025 in 1q21.1,
6.28 3 1022 in 1q21.2, and 3 3 1024 in 1q21.3). In contrast,
when stratifying the samples based on KDM4B amplification
status (Figures 6G–6I and S6G–S6I), the differences are not sig-
nificant (all p values > 0.1 by Fisher’s exact test), although a
minimal trend in the same direction is observed. These results
demonstrate that KDM4A amplification in tumors correlated
with amplification of specific cytogenetic bands, which suggests
that KDM4A may promote site-specific copy gains in vivo.
Copy Gain and Rereplication Occur in Regions
Coamplified in Tumors
Because 1q21.1-1q21.3 amplification correlated with KDM4A
amplification, we assessed whether these regions were gained
by FISH and rereplicated by density gradient centrifugation in
transgenic cell lines. We observed increased copy number of
1q12 through 1q21.2 in our KDM4A-overexpressing cells, but
not in control cells (Figures 7A and 7B). Our coamplificationin Cancer
A in cancer. The blue line represents the locus of KDM4A, and its gene-specific
lue dot represents the gene-specific significance of KDM4B.
A in 547 ovarian cancer samples. The blue line represents the locus of KDM4A,
ot, blue shaded regions indicate 1p11.2 through 1q21.3, and red dashed lines
1.1 p = 23 109 for +2 versus 0 and p = 2.043 1025 for +1 versus 0 by Fisher’s
.9 3 109 for +2 versus 0 and p = 6.28 3 1022 for +1 versus 0).
.02 3 1010 for +2 versus 0 and 3 3 1024 for +1 versus 0).
1q21.1 (p = 0.18 for +2 versus 0).
1q21.2 (p = 0.22 for +2 versus 0).
ber of 1q21.3 (p = 0.24 for +2 versus 0).
st. NS, not significantly different than 0. See also Figure S6.
Cell 154, 541–555, August 1, 2013 ª2013 Elsevier Inc. 549
(legend on next page)
550 Cell 154, 541–555, August 1, 2013 ª2013 Elsevier Inc.
analysis of all tumors indicated that the correlation with KDM4A
copy number diminished at 1q23.3, suggesting that 1q23.3 is not
amplified in KDM4A-overexpressing cells, which was in fact the
case in KDM4A-overexpressing RPE cells (Figures 7A and 7B).
We then evaluated copy gain of other chromosomal domains
identified through our coamplification analysis. We chose to
examine the small focal peak on the X chromosome (Xp11.2-
Xq13.2), which was specific to coamplification with KDM4A
across all cancers andwas evenmore enriched in ovarian cancer
(Figures 6A and 6C, respectively). KDM4A-overexpressing RPE
cells exhibited Xq13.1 copy gains, but not the X centromere or
Xq13.2 (Figures 7C and 7D). Xq13.1 as well as 1q12/21 and
1q21.2 copy gains were also observed in 293T cells overex-
pressing KDM4A (Figure S6J). These data demonstrate that
KDM4A-coamplified regions in primary tumors are generated
by KDM4A overexpression in transgenic cell lines.
The coamplification analysis of tumor data sets does not
distinguish whether the entire intervening sequence between
1q12h and 1q21.3 was amplified in the same tumor cells. There-
fore, we scored the 1q12/21 or 1q21.2 FISH probes with the
1q12h probe in the same KDM4A-overexpressing cells (Figures
7A and 7E–7U). We observed that approximately two-thirds of
the KDM4A-overexpressing cells with 1q12h amplification also
had 1q12/21.1 amplification, whereas approximately one-third
had only 1q12/21.1 copy gain but lacked 1q12h gain (Figure 7U).
In the case of 1q12h or 1q21.2 amplification, the majority of cells
had gains in one or the other cytogenetic band (Figures 7M–7U).
Taken together, these data demonstrate that the entire region
between 1q12h and 1q21.3 is not contiguously amplified but
that KDM4A is directing copy gain within these cytogenetic
bands. The ability to detect nonoverlapping foci also suggests
that the additional copies may exist as extrachromosomal
pieces. This possibility was further supported by the fact that
1q12/21 FISH marked the additional 1q12/21 copy adjacent to
or physically distinct from the chromosome 1 painted territory
(Figures S7A–S7L).
To address whether these gained regions were through rere-
plication, we assayed our CsCl gradient H:H fraction for regions
under our FISH probes in the indicated cytogenetic bands (Fig-
ure 7V). We observed rereplication at 1q12h (indicated by Chr1
sat2), 1q12/21.1, 1q21.2, and 1q21.3, but not in 1q23.3 or on
Chr10. Rereplication was detected inside Xq13.1, but not near
the X centromere. In addition, the rereplicated regions wereFigure 7. KDM4A Overexpression Leads to Copy Gains and Rereplicat
(A) Chromosome arm schematic depicting location of FISH probes used on chro
(B) KDM4A overexpression increased copy number of 1q12h, 1q12/21.1, and 1q
(C) Chromosome arm schematic depicting location of FISH probes used on chro
(D) KDM4A overexpression increases copy number of Xq13.1, but not X cen or X
(E–T) FISH of stable RPE cells overexpressing GFP-CTRL or GFP-KDM4A with i
(U) Table summarizing coamplification of 1q12h, 1q12/21.1, and 1q21.2 in (E)–(T).
indicated FISH probes.
(V) KDM4A-dependent rereplication of chromosomal domains.
(W) KDM4A ChIP in HU-arrested cells. KDM4A is enriched in rereplicated region
(X) HP1g enrichment decreases at rereplicated regions in KDM4A-overexpressin
(Y and Z) MCM7 and DNA polymerase a (Pol a) are enriched at rereplicated regi
Error bars represent the SEM. Asterisk indicates significant difference from GFP
t test. For rereplication (V) and ChIP experiments (W–Z), Chr1 sat2 and Chr10 ar
See also Figures S6 and S7.bound by KDM4A, which was further enriched upon KDM4A
overexpression (Figures 7W and S6K). As with Chr1 sat2,
KDM4A overexpression promoted loss of HP1g (Figure 7X) and
recruitment of MCM7 and Pola to 1q21.2 and Xq13.1 (Figures
7Y and 7Z, respectively). Taken together, our data are consistent
with the model that KDM4A overexpression promotes copy gain
and rereplication at specific sites within the genome in vivo (tu-
mors) and in vitro (transgenic cell lines).
DISCUSSION
Genomic instability is a major contributing factor to the develop-
ment and onset of age-related diseases. Cancer cells often
contain alterations in copy number of genes, specific genomic
regions, chromosome arms, and entire chromosomes. However,
the underlying molecular mechanisms that lead to these copy
number alterations are poorly understood. Here, we report that
overexpression of a single chromatin modifying enzyme,
KDM4A, is sufficient to promote rereplication and copy gain of
specific chromosomal domains. Furthermore, KDM4A-depen-
dent amplified regions are found coamplified with KDM4A in pri-
mary tumors. Our results support a model in which increased
expression of KDM4A promotes recruitment of KDM4A to spe-
cific genomic regions and promotes rereplication (Figure S7M).
KDM4 Members and Cancer
Our results demonstrate that KDM4A is amplified in different
tumor types and correlates with increased KDM4A expression.
Intriguingly, when compared to other tumor types, ovarian can-
cer is enriched for amplifications of KDM4A, which correlate
with poor outcome in these cases. Levels of KDM4A may there-
fore represent a good biomarker for ovarian cancer, especially
with respect to novel therapies that target this lysine demethy-
lase. In addition, ovarian patients with increased levels of
KDM4A may respond more poorly to S-phase chemotherapeu-
tics, as KDM4A overexpression resulted in better recovery
from HU (Black et al., 2010). Consistent with this possibility,
ovarian cell lines with 1q12-21 amplification are oftenmore resis-
tant to cisplatin treatment (Kudoh et al., 1999; Takano et al.,
2001). Interestingly, drug resistance in multiple myeloma is
also associated with 1q12-21 amplification (Inoue et al., 2004).
Addressing the relationship between KDM4A, 1q12-21 coampli-
fication, and drug responses will be important in future studies.ion of Regions Coamplified in Tumors
mosome 1.
21.2, but not 1q23.3.
mosome X.
q13.2 in RPE cells.
ndicated FISH probes.
Data are presented as percentage of amplified cells having 2 or 3+ copies of the
s in KDM4A-overexpressing RPE cells.
g cells following 1 hr release from HU arrest.
ons in HU-arrested KDM4A-overexpressing cells, respectively.
-CTRL or comparison indicated by bracket (p < 0.05) by two-tailed Student’s
e the data presented in Figure 5 for reference. Scale bars, 2 mm.
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Even though KDM4 family members have a high degree of
homology, they have different distribution of genomic anomalies
in cancer. We observed focal deletions in KDM4B-D, whereas
none were observed in KDM4A across the eight different tumor
types (Figures S1A–S1D). We also found that KDM4A was the
only family member that had a correlation between focal ampli-
fication and poor outcome for ovarian cancer patients. Thus, it
is intriguing to speculate that KDM4 family enzymes may play
different roles in ovarian cancer and other tumor types. Overall,
our data highlight the idea that these family members are not
created equal but, most likely, have their own specific roles in
cancer and in other diseases.
Chromatin Environment and KDM4A-Dependent
Copy Gain
Work in yeast demonstrates that specific genomic regions can
generate extra DNA fragments in S phase, which depends on
the chromatin environment (Kiang et al., 2010). These observa-
tions are consistent with our KDM4A-dependent rereplication
of specific chromosomal regions. These regions are enriched
for KDM4A binding upon overexpression of KDM4A, rereplicate,
and have increased copy number during S phase. Interestingly,
not all KDM4A-occupied sites are rereplicating in the cell lines
tested (Figure 7V). However, this could reflect the chromatin
environment in these particular cells or distinct chromatin states
influenced by other chromatin modifiers. This would be consis-
tent with our ability to see Xq13.1 and X centromere copy gain
in KDM4A focally amplified tumors while only seeing the copy
gain and rereplication of Xq13.1 in our transgenic cell lines.
Thus, different genomic regions may be susceptible to
KDM4A-dependent rereplication in specific tissue types.
Consistent with the model that chromatin state impacts copy
gain, we demonstrated that interfering with H3K9 or K36 methyl-
ation resulted in the site-specific gain of 1q12h in 24 hr, whereas
overexpression of Suv39h1 or HP1g was able to suppress the
1q12h gain. Surprisingly, we were unable to reverse KDM4A-
dependent copy gains in cells stably overexpressing KDM4A
by overexpressing HP1g even though these copy gains are re-
generated each cell cycle. This observation supports a model
whereby KDM4A may establish a chromatin state that promotes
rereplication and increased copy number of specific chromo-
somal regions. Formation of this chromatin state could be antag-
onized by HP1g, but not reversed once established. Taken
together, these data strongly suggest that the reader, the lysine,
and the KDM/KMT balance are required to maintain regulation at
these regions. Therefore, we hypothesize that the local chro-
matin environment will be an important determinant in desig-
nating whether certain regions are more susceptible to copy
gains and rereplication (see Figure S7M). Based on our observa-
tions, we also believe that other methyltransferases or chromatin
modulators (e.g., readers or remodelers) may be able to block or
reset the established chromatin state in KDM4A-overexpressing
cells or that these modulators may have their own independent
roles in regulating site-specific copy gains.
KDM4A and Rereplication
Increased KDM4A occupancy promotes a more open chromatin
environment through decreasing H3K9me3 and HP1g occu-552 Cell 154, 541–555, August 1, 2013 ª2013 Elsevier Inc.pancy (Figure S7M; Black et al., 2010). KDM4A overexpression
also promotes recruitment of the replication licensing machinery
and DNA polymerases to sites of rereplication and copy gain
(Figure S7M, model). Because copy gains require the KDM4A
Tudor domains, we favor the model that KDM4A directly
increased chromatin accessibility and, in turn, loading of the
MCM and replication complex on chromatin (Figure S7M). This
loading and rereplication could occur in the absence of CDT1,
CDC6, and ORC, as they are not necessary for replication after
MCMs have been successfully loaded (Arias and Walter, 2007).
However, the more open chromatin could independently pro-
mote inappropriate recruitment of MCMs and DNA polymerases
to unused or reused origins, thus promoting rereplication (Fig-
ure S7M). This later model would be consistent with the observa-
tion that interfering with H3K9 or K36 methylation can promote
the site-specific gain in cells with wild-type KDM4A levels.
Regardless of the exact details, the data presented in this study
support the model that alterations of heterochromatin and
methylation at specific regions are more prone to rereplication
and, in turn, copy gain.
KDM4A and Extrachromosomal DNA
Because the extra copies of 1q12 are not inherited but are
removed prior to completion of G2, it is likely that such regions
exist as extrachromosomal DNA (Figures S7H and S7L). As
such, it is possible that KDM4A is promoting rereplication at re-
gions that promote head-to-tail collision of one replication fork
chasing another (Figure S7M). This model fits a previous study
showing that deregulation of replication licensing promotes
DNA fragmentation and was consistent with fork collision (Da-
vidson et al., 2006). The presence of these fragments could
also explain why KDM4A-overexpressing cells exhibit a moder-
ate increase in p53 stabilization (Figure S2H); that remains
below the threshold required to elicit the p53 checkpoint (Kraci-
kova et al., 2013). It is also possible that site-specific rereplica-
tion may not be restricted to cancer cells. Transiently upregulat-
ing enzymes that direct site-specific rereplication to increase
copy number of specific genes may be a general mechanism
to allow cells the plasticity to respond to developmental, envi-
ronmental, or stress conditions without altering their genetic
makeup.
KDM4A-Dependent Transient Copy Gain
Because transient KDM4A overexpression was sufficient to
promote localized changes in copy number in a single cell cycle,
the amplification of specific regions may precede genetic
changes in tumors. For instance, transient misregulation of chro-
matin regulators by altered environmental factors, metabolic
changes, hypoxia, or miRNAs could lead to temporary changes
in copy number of small genomic regions. If these regions
contain oncogenes, this could create a feedback loop that pro-
motes tumorigenesis while masking the originating event (e.g.,
transient upregulation of KDM4A). Of note, several putative
oncogenes reside in the 1q12 and 1q21 cytogenetic bands,
including BCL9 andMCL1. In fact, KDM4A binds theBCL9 locus
and causes both copy gain and rereplication of this site (1q21.2
region, Figures 7W and 7V, respectively). However, we do not
observe increased expression of Bcl9, which likely reflects the
lack of additional stimulus, transcription factors, or the low per-
centage of cells with this particular copy gain (data not shown).
It remains unclear how the rereplicated regions are removed
as cells exit S phase and enter G2/M. It is possible that cells
possess an active method for degradation or removal of these
regions. Understanding the events leading to removal of inap-
propriately amplified regions could be critical to helping to iden-
tify pathways that may be misregulated in cancer and lead to the
accumulation and inheritance of copy number changes. We
hypothesize that other events could then promote incorporation
of these transiently amplified regions and, in turn, influence
tumorigenesis.Conclusions
It is clear that the chromatin context influences replication timing
and initiation choices. However, chromatin may additionally play
an important role in ensuring replication fidelity and preventing
rereplication. Distinct chromatin domains may have increased
propensity for rereplication under different circumstances and
cell types. This is supported by work in Drosophila that demon-
strates that heterochromatic regions rereplicate upon loss of
geminin (Ding and MacAlpine, 2010). Additionally, some chro-
matin modifiers such as KMT5A/B/C regulate rereplication on a
more global scale (Beck et al., 2012; Tardat et al., 2010). Taken
together, these results suggest that proper regulation of chro-
matin state is critical for suppressing rereplication. Therefore, a
‘‘chromatin checkpoint’’ may be intimately associated with the
timing of replication and the propensity to undergo rereplication
and copy gain.
Although we have uncovered a single enzyme that can regu-
late site-specific copy gain, several additional questions remain
to be answered (Figure S7M). How does the chromatin environ-
ment regulate CNV? Is regulation of methylation of nonhistone
substrates involved in modulating copy number (e.g., replication
machinery and/or HP1)? Do additional chromatinmodifiers regu-
late CNV and contribute to tumor heterogeneity? What events
could promote transient copy gains to be inherited? Future
studies that identify additional factors and/or stimuli that address
these questions will allow for a more complete picture surround-
ing copy number variation, rereplication, genome stability, and
cancer to emerge.EXPERIMENTAL PROCEDURES
Extended Experimental Procedures are included in the Supplemental
Information.Cell Culture
Generation of stable cell lines, constructs, and antibodies used can be found in
the Extended Experimental Procedures. Transient H3.3 variant RPE cells were
transduced with lentiviral stocks provided from the Allis lab in the presence of
8 mg/ml polybrene for 8 hr (Lewis et al., 2013).Subcellular Localization and Catalytic Activity of KDM4A Deletion
Fragments
H3K36me3 and subcellular localization were assayed by examining trans-
fected cells (positive for HA staining; HA.11 Covance) following fixation in
3.7% PFA in PBS (Whetstine et al., 2006).Immunoprecipitation and Chromatin Immunoprecipitation
HaloTag-purified KDM4A complexes were analyzed and processed by MS
Bioworks (Ann Arbor, Michigan), with details in the Extended Experimental
Procedures. Immunoprecipitations (IP) were performed essentially as
described in Van Rechem et al. (2011).
Chromatin IPs were performed as in Black et al. (2010) with some
minor changes. Sonication was performed using a Qsonica Q800R
system with a constant chiller. RPE cells were arrested in 2 mM HU for
20 hr prior to crosslinking to assess enrichment in KDM4A, HP1g,
H3K9me3, H3K36me3, and DNA polymerase a at G1/S transition. Data
presented are averages from the two independently prepared polyclonal
RPE cell lines from at least two independent chromatin preparations per
cell line.Fluorescent In Situ Hybridization
Fluorescent in situ hybridization (FISH) was performed as described in Mann-
ing et al. (2010). Probes for 1q12h, 1q telomere, 6p21/chr 14 IGH translocation,
and chromosomes 2, 6, 8, and X alpha satellite were purchased from Rainbow
Scientific. Probes for 1q12/21.1 (RP11-17L12), Xq13.2 (RP11-451A22), and
Xq13.1 (RP11-177A4) were purchased as BAC clones fromChildren’s Hospital
Oakland Research Institute (CHORI BacPac) FISH verified clone repository.
Probes for 1q21.2 (BCL9) and 1q23.3were purchased fromAgilent (SureFISH).
For RPE cells, copy gain was scored as any cell with three ormore distinct foci.
For 293T cells, copy gain was scored for any cell with five or more distinct foci.
Comprehensive methods can be found in the Extended Experimental
Procedures.Cesium Chloride Gradient Centrifugation
RPE cells were treated with 100 mM BrdU 14 hr prior to harvest. DNA was
purified, digested with RNase A, EcoRI, and BamHI (NEB), and resuspended
in TE. 100 mg of DNA was mixed with CsCl in TE (refractive index of 1.4015–
1.4031). The CsCl gradient was centrifuged at 44,400 RPM in a VTi-65 rotor
for 72 hr at 25C. Fractions were collected in 200 ml aliquots, and DNA con-
centration was measured by Nanodrop. Appropriate fractions were pooled,
dialyzed, concentrated, and ethanol precipitated. Each rereplicated pool
was diluted to 15 ng/ul stock, and 7.5 ng of rereplicated DNA pool was
analyzed by qPCR. Each sample was normalized to its own input prior to
determination of fold change in rereplication. Primers used in this study will
be provided upon request.Determination of Cytoband Copy Number and Correlation with
KDM4A
Sample-specific mean focal copy numbers for 807 cytobands including X
chromosome were annotated by taking an average of GISTIC annotated
focal copy numbers for every gene within the same cytoband. The p values
for the mean focal copy number changes between KDM4A copy-gained
samples (GISTIC annotation = +1 or +2) and KDM4A copy-neutral samples
(GISTIC annotation = 0) across 807 cytobands were annotated by two inde-
pendent statistical tests (Figures 6A–6C and S6A–S6C; see the Extended
Experimental Procedures for details). As positive controls, we also calculated
the significance using the gene-specific copy number for KDM4A and
KDM4B. The empirical cumulative distribution functions (the fraction of sam-
ples below the given mean focal copy) were determined by enumerating
samples having the mean focal copy number less than or equal to the value
on the x axis in Figures S6D–S6I for KDM4A- and KDM4B-amplified (+2),
copy-gained (+1), and copy-neutral samples (0). Procedures for RNA-seq
and ovarian cancer outcome can be found in the Extended Experimental
Procedures.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and one table and can be found with this article online at http://dx.doi.
org/10.1016/j.cell.2013.06.051.Cell 154, 541–555, August 1, 2013 ª2013 Elsevier Inc. 553
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